[Congressional Record Volume 162, Number 32 (Monday, February 29, 2016)]
[Senate]
[Page S1093]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3331. Mr. DURBIN submitted an amendment intended to be proposed by 
him to the bill S. 524, to authorize the Attorney General to award 
grants to address the national epidemics of prescription opioid abuse 
and heroin use; which was ordered to lie on the table; as follows:

       At the end of title VI, insert the following:

     SEC. 602. PRIORITY CONSIDERATION.

       (a) Definitions.--The definitions in section 601(a) shall 
     apply to this section.
       (b) Priority Consideration.--In awarding Federal funds 
     under a program of the Department of Justice or the 
     Department of Health and Human Services to be used for 
     prescription drug monitoring programs of the States, the 
     Attorney General or the Secretary of Health and Human 
     Services, as the case may be, shall give priority 
     consideration to an application from a State that--
       (1) requires a prescriber of a schedule II, III, or IV 
     controlled substance to, prior to the issuance of a 
     prescription for a schedule II, III, or IV controlled 
     substance, consult the prescription drug monitoring database 
     of the State;
       (2) requires a dispenser of a schedule II, III, or IV 
     controlled substance to, for the dispensing of each 
     prescription of a schedule II, III, or IV controlled 
     substance, input data to the prescription drug monitoring 
     database of the State, within 24 hours of the dispensing, 
     which shall include--
       (A) a patient identifier;
       (B) the national drug code of the dispensed drug;
       (C) the date of dispensing;
       (D) the quantity of the drug dispensed;
       (E) the Drug Enforcement Administration registration number 
     of the prescriber; and
       (F) the Drug Enforcement Administration registration number 
     of the dispenser;
       (3) authorizes access to a State board responsible for the 
     licensure, regulation, or discipline of practitioners, 
     pharmacists, or other person who is authorized to prescribe, 
     administer, or dispense controlled substances; and
       (4) requires that, not fewer than 4 times a year, the State 
     agency that administers the prescription drug monitoring 
     program of the State prepare and provide to--
       (A) the State board described in paragraph (3), an 
     informational report concerning the prescribing patterns of 
     prescribers within the State, which shall include data on 
     aggregate trends and individual outliers that indicate a 
     substantial likelihood that inappropriate prescribing may be 
     occurring; and
       (B) each prescriber of a schedule II, III, or IV controlled 
     substance, an information report that shows how the 
     prescribing patterns of the prescriber compare to the 
     prescribing practices of the peers of the prescriber and 
     expected norms.
                                 ______